Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HMGN2 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | ZNF548 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | CEP68 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
mRNA | TSNARE1 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | CERKL | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | SH2D3C | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-07 |
mRNA | PSMD4 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |
mRNA | STARD9 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
mRNA | PHF2 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | CCDC177 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |